Trials / Sponsors / Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors Basal Cell Carcinoma, Medulloblastoma, Adenocarcinoma of Esophagogastric Junction | Phase 1 | 2019-01-25 |
| Unknown | A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors Hepatocellular Carcinoma, Cholangiocarcinoma, Gastric Cancer | Phase 1 | 2018-11-13 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. Influenza | Phase 1 | 2018-09-20 |
| Completed | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Idiopathic Pulmonary Fibrosis(IPF), Solid Tumor | Phase 1 | 2018-07-16 |
| Completed | Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2018-01-05 |